Clinical Dermatology I (Original MDlive series)

Dr. Lebwohl heads one of the leading dermatology programs in the nation. Under his direction, extraordinary recruits in medical dermatology have developed safer, more effective therapies in skin cancer, psoriasis, vitiligo, eczema, and many other dermatologic diseases.

Dr. Lebwohl's main areas of clinical interest include skin cancer and psoriasis. One of the first topical therapies approved for skin cancer and for precancerous lesions was identified by Dr. Lebwohl, and many of the systemic and topical therapies for psoriasis were studied or developed in Mount Sinai's Department of Dermatology.

Dr. Lebwohl earned Presidential Citations from the American Academy of Dermatology recognizing his exceptional leadership and vision. He has been given Lifetime Achievement Awards by the National Psoriasis Foundation and by the American Skin Association, and the Journal of Drugs in Dermatology named him a Leader of Distinction. He holds honorary memberships in the Florida Society of Dermatology and Dermatologic Surgery, the Pacific Dermatology Association, the Canadian Dermatology Association, and the French Society of Dermatology, as well as the American Osteopathic College of Dermatology. His most treasured award, presented by Mount Sinai’s dermatology residents, was for Best Teacher and Mentor of the Millennium. He earned further distinction when Medical Economics Magazine named his department a Clinical Center of Excellence–one of just eight institutions in the country so designated. Dr. Lebwohl is frequently an invited visiting professor and speaker at universities, medical centers, and professional meetings worldwide.

After earning his medical degree from Harvard Medical School, Dr. Lebwohl came to Mount Sinai to complete residencies in both internal medicine and dermatology. He joined the Mount Sinai faculty in 1983 as an assistant professor. He was named Chair of the Department of Dermatology in 1997.